Immune Checkpoint Inhibitor Use Near the End of Life: A Single-Center Retrospective Study-Reference-Cited by-同舟云学术

Immune Checkpoint Inhibitor Use Near the End of Life: A Single-Center Retrospective Study

Published:2020-07-01 Issue:7 Volume:23 Page:977-979
ISSN:1096-6218
Container-title:Journal of Palliative Medicine
language:en
Short-container-title:Journal of Palliative Medicine

Author:

Glisch Chad¹,Saeidzadeh Seyedehtanaz²,Snyders Travis³,Gilbertson-White Stephanie²,Hagiwara Yuya⁴,Lyckholm Laurel³

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

2. College of Nursing, University of Iowa, Iowa City, Iowa, USA.

3. Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

4. Supportive and Palliative Care Program, Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

Publisher

Mary Ann Liebert Inc

Subject

Anesthesiology and Pain Medicine,General Medicine,General Nursing

Link

https://www.liebertpub.com/doi/pdf/10.1089/jpm.2019.0383

Reference7 articles.

1. Cancer treatment in the last 6 months of life: when inaction can outperform action

2. 2. Kolata G: ‘Desperation Oncology’: When Patients Are Dying, Some Cancer Doctors Turn to Immunotherapy, in New York Times, New York, NY: The New York Times Company, 2018.

3. Immune Checkpoint Inhibitor Use Near the End of Life Is Associated With Poor Performance Status, Lower Hospice Enrollment, and Dying in the Hospital

4. Checkpoint Inhibitors, Palliative Care, or Hospice

5. Keeping Expectations in Check With Immune Checkpoint Inhibitors

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why and How to Integrate Early Palliative Care Into Cutting-Edge Personalized Cancer Care;American Society of Clinical Oncology Educational Book;2024-06

2. Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US;JAMA Oncology;2024-03-01

3. Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective;Cancers;2023-12-24

4. Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors;The Oncologist;2023-08-05

5. The Cost of Cancer Care at the End of Life: Implications for Centers for Medicare and Medicaid Services and for Radiation Oncology;International Journal of Radiation Oncology*Biology*Physics;2023-07